v3.25.1
Segment Information - Segment Reporting Information, by Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Segment Reporting Information [Line Items]    
Segment and consolidated net loss $ 22,970 $ 13,311
Reportable Segment    
Segment Reporting Information [Line Items]    
Research and development payroll-related costs 5,232 3,028
General and administrative payroll-related costs 2,154 1,549
Clinical trial expenses 6,009 2,195
Chemistry, manufacturing, and controls costs 4,346 4,393
Medical affairs expenses 555 286
Research and development consulting expenses 1,372 832
General and administrative consulting expenses 1,036 1,989
Other segment items 2,266 (961)
Segment and consolidated net loss $ 22,970 $ 13,311